Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma: Three case reports

RATIONALE: Refractory nasopharyngeal carcinoma is challenging to treat and at present there is no standard treatment or any good choice. PATIENT CONCERNS: Although the three patients in our case reports had already underwent multiple treatments before, they still suffered from disease recurrence of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Chen, Chen, Liu, Song-Ran, Zhou, Shu, Li, Xiao-Hui, Wang, Xiao-Hui, Tao, Ya-Lan, Chang, Hui, Zhang, Wen-Wen, Li, Wen-Fei, Zhou, Si-Lang, Xia, Yun-Fei
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6709293/
https://ncbi.nlm.nih.gov/pubmed/31393358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016592
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires